Health Canada Approves Medicago’s Covid Vaccine
Health Canada has approved the recombinant Covid-19 vaccine produced by Canadian biotech Medicago that uses the pandemic adjuvant made by British pharma giant GlaxoSmithKline. The shot marketed as Covifenz uses a plant-based virus-like particles technology to imitate the coronavirus’ spike protein.
